Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Post-Covid-19 Olfactory Dysfunction
NCT05184192Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in Olfactory dysfunction, sponsored by Washington University School of Medicine. Started Jan 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT05184192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05184192.